Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study
José L. Pablos, María Galindo, Loreto Carmona, et al.
Annals of the Rheumatic Diseases (2020) Vol. 79, Iss. 12, pp. 1544-1549
Open Access | Times Cited: 226

Showing 1-25 of 226 citing articles:

Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms
Amy D. Proal, Michael B. VanElzakker
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 729
COVID-19 and autoimmune diseases
Yu Liu, Amr H. Sawalha, Qianjin Lu
Current Opinion in Rheumatology (2020) Vol. 33, Iss. 2, pp. 155-162
Open Access | Times Cited: 439
Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms
Bruno Andrade, Sérgio Siqueira, Wagner Rodrigues de Assis Soares, et al.
Viruses (2021) Vol. 13, Iss. 4, pp. 700-700
Open Access | Times Cited: 399
Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis
Wern Hann Ng, Thomas Tipih, Makoah N. Aminake, et al.
mBio (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 271
The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Molecular Diagnostic Testing
Kimberly E. Hanson, Angela M. Caliendo, Cesar Andres Diaz Arias, et al.
Clinical Infectious Diseases (2021) Vol. 78, Iss. 7, pp. e170-e207
Open Access | Times Cited: 175
Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial
Ana Cristina de Medeiros Ribeiro, Nádia Emi Aikawa, Carla Gonçalves Schahin Saad, et al.
Nature Medicine (2021) Vol. 27, Iss. 10, pp. 1744-1751
Open Access | Times Cited: 175
SARS–CoV‐2 Infection and COVID‐19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta‐Analysis
Richard Conway, Alyssa Grimshaw, Maximilian F. Konig, et al.
Arthritis & Rheumatology (2021) Vol. 74, Iss. 5, pp. 766-775
Open Access | Times Cited: 158
Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)
Zaki A. Sherif, Christian R. Gómez, Thomas J. Connors, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 151
COVID‐19 Outcomes in Patients With Systemic Autoimmune Rheumatic Diseases Compared to the General Population: A US Multicenter, Comparative Cohort Study
Kristin M. D’Silva, April Jorge, A. N. Cohen, et al.
Arthritis & Rheumatology (2020) Vol. 73, Iss. 6, pp. 914-920
Open Access | Times Cited: 144
Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study
Youn Ho Shin, Jae Il Shin, Sung Yong Moon, et al.
The Lancet Rheumatology (2021) Vol. 3, Iss. 10, pp. e698-e706
Open Access | Times Cited: 116
Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases
Rebecca Hasseli, Ulf Müeller-Ladner, Bimba F. Hoyer, et al.
RMD Open (2021) Vol. 7, Iss. 1, pp. e001464-e001464
Open Access | Times Cited: 112
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups
Clodoveo Ferri, Francesco Ursini, Laura Gragnani, et al.
Journal of Autoimmunity (2021) Vol. 125, pp. 102744-102744
Open Access | Times Cited: 109
Prognostic factors for mortality, intensive care unit and hospital admission due to SARS-CoV-2: a systematic review and meta-analysis of cohort studies in Europe
Constantine Vardavas, Alexander G. Mathioudakis, Katerina Nikitara, et al.
European Respiratory Review (2022) Vol. 31, Iss. 166, pp. 220098-220098
Open Access | Times Cited: 76
Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
Levente Zsichla, Viktor Müller
Viruses (2023) Vol. 15, Iss. 1, pp. 175-175
Open Access | Times Cited: 66
Global prevalence and effect of comorbidities and smoking status on severity and mortality of COVID-19 in association with age and gender: a systematic review, meta-analysis and meta-regression
Santenna Chenchula, Kota Vidyasagar, Saman Pathan, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 40
Obesity as an independent risk factor for COVID-19 severity and mortality
Borna Tadayon Najafabadi, Daniel Rayner, Kamyar Shokraee, et al.
Cochrane library (2023) Vol. 2023, Iss. 6
Open Access | Times Cited: 40
Disparities in COVID-19 mortality amongst the immunosuppressed: A systematic review and meta-analysis for enhanced disease surveillance
Meredith Leston, Willam Elson, José M. Ordóñez‐Mena, et al.
Journal of Infection (2024) Vol. 88, Iss. 3, pp. 106110-106110
Open Access | Times Cited: 15
Incidence and severeness of COVID-19 hospitalization in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark
René Cordtz, Jesper Lindhardsen, B. G. Soussi, et al.
Lara D. Veeken (2020) Vol. 60, Iss. SI, pp. SI59-SI67
Open Access | Times Cited: 120
Epidemiology of Pemphigus
Khalaf Kridin, Enno Schmidt
JID Innovations (2021) Vol. 1, Iss. 1, pp. 100004-100004
Open Access | Times Cited: 95
COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses
Filippo Fagni, David Simón, Koray Taşçılar, et al.
The Lancet Rheumatology (2021) Vol. 3, Iss. 10, pp. e724-e736
Open Access | Times Cited: 94
Coronavirus disease 2019 outcomes among patients with rheumatic diseases 6 months into the pandemic
Naomi Serling‐Boyd, Kristin M. D’Silva, Tiffany Hsu, et al.
Annals of the Rheumatic Diseases (2020) Vol. 80, Iss. 5, pp. 660-666
Open Access | Times Cited: 92
Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study
Hannah Bower, Thomas Frisell, Daniela Di Giuseppe, et al.
Annals of the Rheumatic Diseases (2021) Vol. 80, Iss. 8, pp. 1086-1093
Open Access | Times Cited: 91
Outcomes of COVID-19 in patients with rheumatoid arthritis: A multicenter research network study in the United States
Rahul Raiker, Charles DeYoung, Haig Pakhchanian, et al.
Seminars in Arthritis and Rheumatism (2021) Vol. 51, Iss. 5, pp. 1057-1066
Open Access | Times Cited: 73
Temporal trends in severe COVID-19 outcomes in patients with rheumatic disease: a cohort study
April Jorge, Kristin M. D’Silva, A. N. Cohen, et al.
The Lancet Rheumatology (2020) Vol. 3, Iss. 2, pp. e131-e137
Open Access | Times Cited: 69
Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic
Sakir Ahmed, Armen Yuri Gasparyan, Olena Zimba
Rheumatology International (2021) Vol. 41, Iss. 2, pp. 243-256
Open Access | Times Cited: 68
Page 1 - Next Page

Scroll to top